Eledon Pharmaceuticals Inc. (ELDN)
Market Closed
17 Jul, 20:00
$
4. 07
+0.23
+5.9896%
$
230.8M Market Cap
- P/E Ratio
- Div Yield
787,200 Volume
-1.78 Eps
$ 3.84
Previous Close 
Want to track ELDN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eledon Pharmaceuticals Inc. (ELDN) Statistics
Valuation metrics
Market Cap 230.8M
Enterprise value 238.4M
Trailing P/E (ttm) -4.68
Forward P/E -4.31
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 4.55
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.06
Overview
Shares outstanding 75.43M
Float 68.59M
Shares short 7.19M
% Held by insiders 0.01%
% Held by institutions 0.62%
Average volume (10 days) 1.02M
Average volume (90 days) 1.25M
Price summary
52-Week low 1.35
52-Week high 4.6
Beta 0.84
50-Day moving average 3.82
200-Day moving average 2.91
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:18
Last split Date 5 Oct 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.53%
Return on equity -0.97%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -45.62M
Diluted EPS (ttm) -0.7
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 133.34M
Total cash per share (mrq) 0.99
Total debt (mrq) 641K
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 8.44%
Book value per share (mrq) 0.89
Cash Flow
Cash flow statement -62.34M
Levered free cash flow (LFCF) -33.66M
